medac group has acquired Biotech Pharma, a pharmaceutical and medical equipment company based in the UAE, for an undisclosed amount. This corporate acquisition signifies a strategic expansion for medac group, integrating a well-established entity that has been providing support and services to healthcare divisions across the Gulf region since its establishment in 2007. Biotech Pharma has built a reputation for its focus on advanced and modern technologies in pharmacy, encompassing biotechnology, nanotechnology, and health robotic pharmacy workflow systems. The company is committed to delivering high-quality health and medical services to its customers throughout the UAE and the broader Gulf region.
Biotech Pharma's operations encompass the distribution of pharmaceutical products across key therapeutic areas such as Oncology, Hematology, Autoimmune, Urology, and Neurosurgery. Its extensive product portfolio includes specialized medications like Metoject® for autoimmune conditions, Bendamustine for oncology, and BCG-medac for urology, alongside a range of medical devices. Critically, the company offers robust regulatory affairs expertise, assisting with marketing authorization applications and lifecycle management for human medicinal products within the Gulf Cooperation Council (GCC) procedure. This regional proficiency, combined with a reliable distribution network extending across the GCC, Jordan, and Yemen, positions Biotech Pharma as a significant regional player dedicated to compliance and customer support.
The acquisition is strategically significant, allowing medac group to leverage Biotech Pharma's deep understanding of the Middle East market, its established product portfolio, and comprehensive regulatory capabilities. This corporate move is expected to create substantial synergies by integrating Biotech Pharma's regional market access and efficient distribution infrastructure with medac group’s existing operations. By bringing together their respective strengths, the combined entity aims to enhance its footprint and broaden the availability of essential pharmaceutical products and medical equipment in the region. Looking ahead, this acquisition is set to strengthen healthcare services by ensuring the efficient delivery of quality medications and advanced medical solutions to patients and healthcare providers throughout the Gulf and surrounding territories, reinforcing commitment to regional health needs.